NL194166C - Naftoxazinen en bereiding en toepassing daarvan. Hexahydronaft[2,3-b]-1,4-oxazinen en farmaceutische preparaten die ze bevatten. - Google Patents

Naftoxazinen en bereiding en toepassing daarvan. Hexahydronaft[2,3-b]-1,4-oxazinen en farmaceutische preparaten die ze bevatten. Download PDF

Info

Publication number
NL194166C
NL194166C NL8501526A NL8501526A NL194166C NL 194166 C NL194166 C NL 194166C NL 8501526 A NL8501526 A NL 8501526A NL 8501526 A NL8501526 A NL 8501526A NL 194166 C NL194166 C NL 194166C
Authority
NL
Netherlands
Prior art keywords
racemate
oxazine
methylene chloride
hexahydro
naphtha
Prior art date
Application number
NL8501526A
Other languages
English (en)
Dutch (nl)
Other versions
NL194166B (nl
NL8501526A (nl
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NL8501526A publication Critical patent/NL8501526A/nl
Publication of NL194166B publication Critical patent/NL194166B/xx
Application granted granted Critical
Publication of NL194166C publication Critical patent/NL194166C/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00—Compounds containing azido groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NL8501526A 1984-06-12 1985-05-29 Naftoxazinen en bereiding en toepassing daarvan. Hexahydronaft[2,3-b]-1,4-oxazinen en farmaceutische preparaten die ze bevatten. NL194166C (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3421729 1984-06-12
DE3421729 1984-06-12
DE3508263 1985-03-08
DE3508263 1985-03-08

Publications (3)

Publication Number Publication Date
NL8501526A NL8501526A (nl) 1986-01-02
NL194166B NL194166B (nl) 2001-04-02
NL194166C true NL194166C (nl) 2001-08-03

Family

ID=25822036

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8501526A NL194166C (nl) 1984-06-12 1985-05-29 Naftoxazinen en bereiding en toepassing daarvan. Hexahydronaft[2,3-b]-1,4-oxazinen en farmaceutische preparaten die ze bevatten.

Country Status (28)

Country Link
US (1) US4656167A (xx)
JP (1) JPS611676A (xx)
AT (1) AT394717B (xx)
AU (1) AU582751B2 (xx)
BE (1) BE902600A (xx)
CA (1) CA1285561C (xx)
CH (1) CH666031A5 (xx)
CY (1) CY1581A (xx)
DE (1) DE3520104C2 (xx)
DK (1) DK172306B1 (xx)
ES (1) ES8704469A1 (xx)
FI (1) FI86301C (xx)
FR (1) FR2565586B1 (xx)
GB (1) GB2160200B (xx)
GR (1) GR851418B (xx)
HK (1) HK11891A (xx)
HU (1) HU193979B (xx)
IE (1) IE58398B1 (xx)
IL (1) IL75468A (xx)
IT (1) IT1200079B (xx)
LU (1) LU85941A1 (xx)
MY (1) MY102059A (xx)
NL (1) NL194166C (xx)
NZ (1) NZ212358A (xx)
PH (1) PH23666A (xx)
PT (1) PT80634B (xx)
SE (1) SE465428B (xx)
SG (1) SG9691G (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8616669D0 (en) * 1986-07-09 1986-08-13 Merk Sharpe & Dohme Ltd Pharmaceutical compositions
US5071875A (en) * 1989-09-25 1991-12-10 Northwestern University Substituted 2-amidotetralins as melatonin agonists and antagonists
HU214591B (hu) * 1989-12-14 1998-04-28 Novartis Ag. Eljárás egy naftoxazinszármazék malonátsójának és az ilyen hatóanyagot tartalmazó gyógyszerkészítmények előállítására
DE4329776A1 (de) * 1993-09-03 1995-03-09 Sandoz Ag Naphthoxazine, ihre Herstellung und Verwendung
TW357143B (en) * 1995-07-07 1999-05-01 Novartis Ag Benzo[g]quinoline derivatives
JP2011525893A (ja) * 2008-06-27 2011-09-29 ハー・ルンドベック・アクチエゼルスカベット 新規のフェノールアミン類およびカテコールアミン類ならびにそのプロドラッグ

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2194421B1 (xx) * 1972-08-03 1975-10-17 Cerpha
AU521527B2 (en) * 1979-09-12 1982-04-08 Dow Chemical Company, The Dehydrohalogenation of (polyhaloalkyl) benzenes
US4368201A (en) * 1981-07-20 1983-01-11 Usv Pharmaceutical Corporation Tetrahydronaphthoxazoles
CA1204745A (en) * 1981-11-20 1986-05-20 Merck Co. Hexahydronaphth (1,2-b) -1,4 -oxazines
US4420480A (en) * 1981-11-20 1983-12-13 Merck & Co., Inc. Hexahydronaphth[1,2-b]-1,4-oxazines
DE4003262A1 (de) * 1990-02-03 1991-08-08 Sandoz Ag Neues naphthoxazin, seine herstellung und verwendung

Also Published As

Publication number Publication date
IE58398B1 (en) 1993-09-08
DE3520104A1 (de) 1985-12-12
DE3520104C2 (de) 1997-01-23
PH23666A (en) 1989-09-27
JPH0576472B2 (xx) 1993-10-22
DK259185A (da) 1985-12-13
NL194166B (nl) 2001-04-02
DK259185D0 (da) 1985-06-10
SE465428B (sv) 1991-09-09
US4656167A (en) 1987-04-07
GB2160200B (en) 1988-03-16
FI852325A0 (fi) 1985-06-11
LU85941A1 (fr) 1986-01-24
GB2160200A (en) 1985-12-18
FI86301C (fi) 1992-08-10
FR2565586B1 (fr) 1989-09-15
AT394717B (de) 1992-06-10
PT80634B (pt) 1987-10-20
BE902600A (fr) 1985-12-06
DK172306B1 (da) 1998-03-09
CH666031A5 (de) 1988-06-30
IT8548195A0 (it) 1985-06-11
NL8501526A (nl) 1986-01-02
NZ212358A (en) 1989-01-27
GB8514636D0 (en) 1985-07-10
ES8704469A1 (es) 1987-04-01
IE851437L (en) 1985-12-12
CY1581A (en) 1992-04-03
HK11891A (en) 1991-02-22
CA1285561C (en) 1991-07-02
SE8502865D0 (sv) 1985-06-10
FI852325L (fi) 1985-12-13
GR851418B (xx) 1985-11-25
SG9691G (en) 1991-04-05
IL75468A0 (en) 1985-10-31
HUT39438A (en) 1986-09-29
ES544074A0 (es) 1987-04-01
JPS611676A (ja) 1986-01-07
AU582751B2 (en) 1989-04-13
SE8502865L (sv) 1985-12-13
FI86301B (fi) 1992-04-30
FR2565586A1 (fr) 1985-12-13
AU4345885A (en) 1985-12-19
MY102059A (en) 1992-03-31
HU193979B (en) 1987-12-28
IT1200079B (it) 1989-01-05
IL75468A (en) 1989-05-15
ATA172385A (de) 1991-11-15
PT80634A (en) 1985-07-01

Similar Documents

Publication Publication Date Title
FI113862B (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 1-piperatsino-1,2-dihydroindeenijohdannaisten valmistamiseksi
CZ283680B6 (cs) Nové azaheterocyklylmethyl-chromany
DK163304B (da) Glutarimidderivat, fremgangsmaade til dets fremstilling og dets anvendelse som angstdaempende og antihypertensivt middel
EP1490361B1 (en) Polycyclic compounds as potent alpha2-adrenoceptor antagonists
IE46087B1 (en) Trisubstituted 1-phenyl-2,3,4,5 - tetra-hydro-1h-3-benzazepine compounds
US4963558A (en) Pyrazolo-[3,4-g]isoquinoline derivatives useful to treat CNS disorders
NL194166C (nl) Naftoxazinen en bereiding en toepassing daarvan. Hexahydronaft[2,3-b]-1,4-oxazinen en farmaceutische preparaten die ze bevatten.
US5084454A (en) 2-(piperidinylmethyl)-4-phenyl-2,3-dihydro-4h-1,4-benzoxazines useful as antipsychotics
FI111945B (fi) Uudet bentsopyrano[3,4-C]pyrroliyhdisteet, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
LU85059A1 (fr) Composes amines heterocycliques et procedes pour leur preparation
AU650792B2 (en) Triazaspirodecanone-methylchromans
AU7860998A (en) New heterocyclic compounds, a process for their preparation and pharmaceutical compositions containing them
US4622326A (en) 6H-isoxazolo(5,4-d)pyrazolo(3,4-b)pyridines, and their use as antihypertensive and analgesic agents
RU2295521C2 (ru) Фотохромные оксазиновые соединения и способы их производства
EP0686637B1 (fr) Dérivés tétracycliques de la 1,4-oxazine, leur procédé de préparation et les compositions pharmaceutiques les contenant
SK158095A3 (en) Application of 1,2-bridged 1,4-dihydropyridines, 1,2-bridged 1,4-dihydropyridines, manufacturing process thereof and pharmaceutical compositions containing them
JPS6130588A (ja) ベンゾ〔ｃ〕〔１，８〕ナフチリジン、その製造方法及びその使用、並びにこれらの化合物を含有する調製剤
EP0246633B1 (en) Trans-benzopyran-[4,3-b]-1,4-oxazine derivatives
IE48427B1 (en) Phenanthrene derivatives,their preparation and pharmaceutical compositions containing them
US5229383A (en) Piperazine-substituted 1,4-benzoxazine derivatives and their use in treating disorders of the central nervous system
HUT61997A (en) Process for producing benzopyran derivatives, as well as antihypertensive and vasodilator pharmaceutical compositions comprising such compounds
WO1998031679A1 (fr) Composes de thiophene et leur application medicinale
GB2174087A (en) Heterocyclic amino compounds
PL150777B1 (pl) Sposób wytwarzania naftooksazyn
EP1421086A1 (en) 2-(AMINOMETHYL)-TETRAHYDRO-9-OXA-1,3-DIAZA-CYCLOPENTA a]NAPHTHALENYL DERIVATIVES WITH ANTIPSYCHOTIC ACTIVITY

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: NOVARTIS AG

BK Erratum

Free format text: PAT. BUL. 10/2001, HEADING P, SECTION 2, PAGE 1179, PATENT NUMBER 194166; THE TITLE OF THE INVENTION SHOULD READ: HEXAHYDRONAFT/(2,3-B/)-1,4-OXAZINEN EN FARMACEUTISCHE PREPARATEN DIE ZE BEVATTEN.

V1 Lapsed because of non-payment of the annual fee

Effective date: 20031201